Clinical Trial Update: Omega-3 Supplementation and Behavior Problems [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating omega-3 supplementation for aggression and antisocial behavior has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Behavior
• Antisocial Behavior
• Antisocial Personality Disorder

Drugs mentioned

• Omega-3 fatty acids supplement (Omega-3 fatty acids)

Snippet

Sponsor: Dr. Annis Fung | Conditions: Aggression, Antisocial Behavior | Phase 2, Phase 3 | Status: COMPLETED